Judge Richard G. Andrews recently denied defendants’ motion to preclude plaintiff’s expert “from testifying about ‘written description’ and that ‘a solution is a solvate[,]‘ . . . in advance of a bench trial in which the expert [was] going to testify in any event.” GlaxoSmithKline LLC v. Anchen Pharms. Inc., et al., C.A. No. 11-46-RGA (D. Del. Dec. 11, 2012). Judge Andrews noted that “live testimony and cross examination” would better able him to reach a “correct decision” on whether the expert’s testimony was appropriate. Id. Judge Andrews also added that defendants’ submission sounded “like cross-examination material[,]” and were he a “cynic” he would think that defendants filed their motion to ensure he was “paying attention when this cross-examination happens.” Id. n.1.